Ultralife Corp. ULBI
Industrial Machinery/Components · IPO 1992 · data as of November 13, 2026
Ultralife Corp. (ULBI) is a company listed in the US with a market value of about $262M. In the twelve months to September 30, 2026 it had revenue of $192M and net income of -$3M, a net margin of -1.5%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 12% a year, a 5-year average ROIC of 1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 60% below the current price.
About Ultralife
Ultralife is listed in the US and classified in industrial machinery/components, IPO year 1992. Revenue went from $66M in 2014 to $191M in 2025, growth of about 10.1% a year. It was profitable in 7 of the last 10 years in our data. Its share count rose by 3% over three years (dilution for shareholders). It spends 5% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $191M | $164M | $159M | $132M | $98M | $108M | $107M | $87M | $86M | $82M |
| Net income | -$3M | -$6M | $6M | $7M | -$119000 | -$234000 | $5M | $5M | $25M | $8M | $4M |
| Free cash flow | -$694000 | $7M | $15M | -$623000 | -$3M | $2M | $19M | -$9M | $7M | $6M | $6M |
| EPS (diluted) | $-0.18 | $-35.00 | $38.00 | $0.44 | $0.05 | $0.05 | $0.00 | $32.00 | $1.53 | $0.00 | $0.23 |
| Net margin | -1.5% | -3.1% | 3.8% | 4.5% | -0.1% | -0.2% | 4.9% | 4.9% | 28.6% | 8.9% | 4.3% |
| ROIC | — | -2.3% | 4.0% | 4.8% | 0.1% | 0.0% | 3.7% | 4.5% | 4.9% | 6.5% | 5.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Ultralife stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 60% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Ultralife pay a dividend?
Not currently.
Is Ultralife a good stock to buy?
We do not give buy or sell advice. Ultralife scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.